Following on from our successful 
National Institute for Health Research (NIHR) Diagnostic Evidence Co-operative Newcastle (DEC), which ran from 2013-2017, and a
fter a competitive national process, Newcastle has been chosen to host one of the NIHR MedTech and In Vitro Diagnostics Co-operatives (MIC) effective from January 2018.  
Our new website is currently under development. We will continue to update this one until it's ready! Please check back again soon!

The NIHR Newcastle In Vitro Diagnostics Co-operative (Newcastle MIC) is one of 11 MICs set up to provide a centre for excellence for the development and evaluation of new effective diagnostic tests.  We will work closely with the diagnostics industry and build expertise and capacity in the NHS to provide evidence on new In Vitro Diagnostics (IVD), medical tests which use a sample of tissue or bodily fluid.  This will enable the test to
 be introduced more rapidly and effectively for patient benefit. Other MICs help to develop new medical technologies. 

The Newcastle MIC is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.  We will build collaborations with: the diagnostic industry; clinicians and other healthcare professionals; patient groups; commissioners; academic researchers including heath economists and other NIHR MICs.  

The Newcastle MIC facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of In Vitro diagnostic medical tests (IVDs) for use in the NHS.
For more information see About us

Newly funded NIHR Medtech and In Vitro Diagnostic Co-operatives announced

To coincide with the publication of the Life Science Industrial Strategy, Health Secretary Jeremy Hunt, announces £14.25 million funding to support 11 NIHR Medtech and In Vitro Diagnostic Co-operatives (MICs). 

News & Development

We have developed a strategy for enhancing patient and public involvement and engagement with the activities of the Newcastle MIC.  We see this as an essential part of the growth and development of our organisation.  The strategy was developed with input from members of the VOICE research support group, a collective of research active citizens who work with universities and external organisations.  You can read our full strategy here.

NIHR DEC Newcastle play key role in development of NICE Guideline

Familial hypercholesterolaemia: identification and management

Evidence reviews for case-finding, diagnosis and statin monotherapy

17/145 - NIHR Efficacy and Mechanism Evaluation (EME) Programme researcher-led will fund ambitious studies evaluating interventions that have the potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. The deadline for applications is 1pm, 27 March 2018

17/136 - NIHR Health Technology Assessment (HTA) Programme - Sepsis. Invites proposals for the evaluation of interventions to improve the identification, diagnosis and management of sepsis. Deadline for  stage 1 applications is 1pm, 28 March 2018 

Biomedical Catalyst 2017 round 4: primer and late stage awards support the development of innovative healthcare products, technologies and processes. Closes Wednesday 7 February 2018 12:00pm. 

Are you set for the Medical Devices Regulations?

Read here for more information and see the following BSI report

£££ See here for recent funding opportunities £££ 

The DEC is funded by the NIHR